...
首页> 外文期刊>International Journal of Food Microbiology >Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection.
【24h】

Anti-infective mechanisms induced by a probiotic Lactobacillus strain against Salmonella enterica serovar Typhimurium infection.

机译:益生菌乳杆菌菌株诱导的抗肠炎沙门氏菌血清型鼠伤寒沙门氏菌感染的抗感染机制。

获取原文
获取原文并翻译 | 示例
           

摘要

The prevention of pathogen infections is one of the most extensively studied effects of probiotics. L. casei CRL 431 is a probiotic bacterium and its effects on the gut immune cells have been extensively studied. The aim of the present study was to determine, using a mouse model, the preventive and therapeutic effect of L. casei CRL 431 to achieve protection against Salmonella enteritidis serovar Typhimurium infection. In both previous and continuous (previous and post-infection) probiotic administration, the mechanisms induced by this lactic acid bacteria on the first line of intestinal defense (non-specific barrier and the innate immune cells associated to the gut), as a way to understand some of the mechanisms involved in the protection against Salmonella enteritidis serovar Typhimurium, were analyzed. The results obtained demonstrated that 7 days L. casei CRL 431 administration before infection decreased the severity of the infection with Salmonella enteritidis serovar Typhimurium, demonstrating that the continuous administration (even after infection) had the best effect. This continuous administration diminished the counts of the pathogen in the intestine as well as its spread outside this organ. Several mechanisms and cells are involved in this protective effect against Salmonella enteritidis serovar Typhimurium. L. casei CRL 431 acted on cells of the innate and adaptive immune response. The probiotic administration decreased the neutrophil infiltration with the consequent diminution of intestinal inflammation; activated the macrophage phagocytic activity in different sites such as Peyer's patches, spleen and peritoneum; and increased the number of IgA+cells in the lamina propria of the small intestine which was correlated with increased release of s-IgA specific against the pathogen in the intestinal fluids. The mechanism of the inhibition of cellular apoptosis was not involved
机译:预防病原体感染是益生菌研究最广泛的作用之一。干酪乳杆菌CRL 431是一种益生菌,已经广泛研究了其对肠道免疫细胞的作用。本研究的目的是确定使用小鼠模型的干酪乳杆菌CRL 431的预防和治疗作用,以实现针对肠炎沙门氏菌血清鼠伤寒沙门氏菌感染的保护。在之前和连续(感染前和感染后)益生菌给药中,这种乳酸菌在肠道防御的第一行(非特异性屏障和与肠道相关的先天免疫细胞)诱导的机制了解了一些针对肠炎沙门氏菌血清型鼠伤寒的保护机制,并进行了分析。所获得的结果表明,在感染前7天施用干酪乳杆菌CRL 431降低了肠炎沙门氏菌血清鼠伤寒沙门氏菌感染的严重性,表明连续施用(即使在感染后)也具有最佳效果。这种连续给药减少了肠道中病原体的数量以及其在该器官外的传播。几种机制和细胞参与了针对肠炎沙门氏菌血清鼠伤寒的保护作用。干酪乳杆菌CRL 431作用于先天性和适应性免疫应答的细胞。益生菌的给药减少了中性粒细胞的浸润,从而减少了肠道炎症。在派伊尔氏淋巴结,脾脏和腹膜等不同部位激活巨噬细胞的吞噬活性;并增加了小肠固有层中IgA +细胞的数量,这与针对肠液中病原体的s-IgA释放的增加有关。不涉及抑制细胞凋亡的机制

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号